Skip to main content
LW

Landon W. Trost

Biography​

Landon W. Trost is a urologist at the Male Fertility and Peyronie's Clinic in Orem, Utah, which he founded in 2019.12 He earned his medical degree at Tulane University School of Medicine and completed urology residency at Mayo Clinic in Rochester, Minnesota.12 His fellowship training included Tulane Medical Center, where he was a clinical research fellow with Wayne J.G. Hellstrom in 2012 to 2013, and Memorial Sloan Kettering Cancer Center.13 He is president-elect of the Sexual Medicine Society of North America.4

Contributions​

His cited work covers Peyronie's disease treatments, including collagenase with penile traction, intralesional interferon, and factors associated with curvature outcomes. Other cited papers address penile prostheses, erectile dysfunction devices, testosterone deficiency, and cosmetic penile enhancement procedures.56789

Cited on WARWIKI

14 publications with Landon W. Trost as a listed author are cited on WARWIKI, ordered by the number of pages that cite them. Papers whose author list is shortened to "et al." before this name are not included.

  1. Trost L, Watter DN, Carrier S, et al. Cosmetic penile enhancement procedures: an SMSNA position statement. J Sex Med. 2024;21(6):573-578. doi
    Cited on: Himplant / Penuma — Subcutaneous Silicone Sleeve · Small Penis Syndrome (SPS) & Penile Dysmorphic Disorder (PDD) · Sliding & Slicing (Penile-Disassembly) Techniques for Peyronie's Disease
  2. Alom M, Sharma KL, Toussi A, Kohler T, Trost L. Efficacy of combined collagenase clostridium histolyticum and RestoreX penile traction therapy in men with Peyronie's disease. J Sex Med. 2019;16:891–900. doi
    Cited on: Peyronie's Disease Agents · Peyronie's Disease · Penile Traction Therapy (PTT)
  3. Mulhall JP, Trost LW, Brannigan RE, et al. "Evaluation and management of testosterone deficiency: AUA guideline." J Urol. 2018;200(2):423–432. doi
    Cited on: Testosterone Replacement Therapy · Hormonal Assessment · Erectile Dysfunction (Condition)
  4. Cahill EM, Trost L. Factors associated with improved curvature outcomes with collagenase clostridium histolyticum for Peyronie's disease: results from a large prospective series. J Sex Med. 2025;22(10):1799-1807. doi
    Cited on: Peyronie's Disease Agents · Penile Traction Therapy (PTT)
  5. Trost LW, Munarriz R, Wang R, Morey A, Levine L. "External mechanical devices and vascular surgery for erectile dysfunction." J Sex Med. 2016;13(11):1579–1617. doi
    Cited on: Small Penis Syndrome (SPS) & Penile Dysmorphic Disorder (PDD) · Penile Traction Therapy (PTT)
  6. Alom M, Burgon H, Ziegelmann M, Köhler T, Helo S, Trost L. "Continuing Collagenase Clostridium Histolyticum Injections Among Initial Nonresponders Results in Significant Curvature Improvements in the Majority of Peyronie's Disease Men." J Sex Med. 2021;18(6):1092-1098. doi
    Cited on: Peyronie's Disease
  7. Hernández JC, Trost L, Köhler T, et al. Emerging Complications Following Alternative Reservoir Placement during Inflatable Penile Prosthesis Placement: A 5-Year Multi-Institutional Experience. J Urol. 2019;201(3):581-586. doi
    Cited on: Non-Infectious Complications of Penile Prosthesis Surgery
  8. Wymer K, Kohler T, Trost L. Comparative Cost-effectiveness of Surgery, Collagenase Clostridium Histolyticum, and Penile Traction Therapy in Men with Peyronie's Disease in an Era of Effective Clinical Treatment. J Sex Med. 2019;16(9):1421-1432. doi
    Cited on: Peyronie's Disease Agents
  9. Wymer K, Ziegelmann M, Savage J, Kohler T, Trost L. "Plaque Calcification: An Important Predictor of Collagenase Clostridium Histolyticum Treatment Outcomes for Men With Peyronie's Disease." Urology. 2018;119:109-114. doi
    Cited on: Peyronie's Disease
  10. Ziegelmann MJ, Viers BR, Lomas DJ, Westerman ME, Trost LW. Ectopic Penile Prosthesis Reservoir Placement: An Anatomic Cadaver Model of the High Submuscular Technique. J Sex Med. 2016;13(9):1425-1431. doi
    Cited on: Reservoir Placement for Three-Piece Inflatable Penile Prostheses
  11. Trost LW, Ates E, Powers M, et al. Outcomes of intralesional interferon-α2B for the treatment of Peyronie disease. J Urol. 2013;190(6):2194-9. doi
    Cited on: Peyronie's Disease Agents
  12. Trost LW, Baum N, Hellstrom WJ. Managing the difficult penile prosthesis patient. J Sex Med. 2013;10(4):893–907. doi
    Cited on: Preoperative Evaluation for Penile Prosthesis Implantation

Footnotes​

  1. Landon W. Trost, MD. Urology. Accessed October 2026. ↩ ↩2 ↩3

  2. About Us. Male Fertility and Peyronie's Clinic. Accessed October 2026. ↩ ↩2

  3. Wayne-Hellstrom-CV-2026-copy_0.pdf. Accessed October 2026. ↩

  4. SMSNA. Board of Directors. Accessed October 2026. ↩

  5. Trost L, Watter DN, Carrier S, et al. Cosmetic penile enhancement procedures: an SMSNA position statement. J Sex Med. 2024;21(6):573-578. doi:10.1093/jsxmed/qdae045 ↩

  6. Alom M, Sharma KL, Toussi A, Kohler T, Trost L. Efficacy of combined collagenase clostridium histolyticum and RestoreX penile traction therapy in men with Peyronie's disease. J Sex Med. 2019;16:891–900. doi:10.1016/j.jsxm.2019.03.007 ↩

  7. Mulhall JP, Trost LW, Brannigan RE, et al. "Evaluation and management of testosterone deficiency: AUA guideline." J Urol. 2018;200(2):423–432. doi:10.1016/j.juro.2018.03.115 ↩

  8. Cahill EM, Trost L. Factors associated with improved curvature outcomes with collagenase clostridium histolyticum for Peyronie's disease: results from a large prospective series. J Sex Med. 2025;22(10):1799-1807. doi:10.1093/jsxmed/qdaf213 ↩

  9. Trost LW, Munarriz R, Wang R, Morey A, Levine L. "External mechanical devices and vascular surgery for erectile dysfunction." J Sex Med. 2016;13(11):1579–1617. doi:10.1016/j.jsxm.2016.09.008 ↩